Prof. Wang was the founding Executive Dean of Academy of Pharmacy. He earned his PhD in Bio-Organic Chemistry from Washington University in St. Louis, Missouri, USA, and was an NIH/NRSA postdoctoral fellow studying mechanisms of DNA repair in mammalian system. Before joining XJTLU, he was a tenured faculty member in the Department of Biochemistry and Molecular Biology at Indiana University School of Medicine (IUSM), USA. He joined the faculty of Indiana University School of Medicine in 2001 as the Scientific Director of a newly established Proteomics Core. In 2004, he spearheaded a biotech CRO, Monarch Life Sciences, and served as Executive VP of Research until 2010. He also served as the director of Protein Analysis Research Center at IUSM from 2001 to 2016. His research centers around biomarkers and drug target discovery, and deciphering the protein interaction networks in complex human diseases such as cancer with the use of high throughput proteomics technologies such as quantitative mass spectrometry platforms. Additionally, he also has expertise in mammalian DNA repair and macro-molecular interaction studies using surface plasmon resonance (SPR) analysis. He has collaborated with more than 100 basic and clinical investigators both across the United States and internationally to advance knowledge related to human health. He has supervised more than 60 graduate students, postdoctoral fellows, and research associates. He was also a Co-Principal Investigator on the U.S. National Cancer Institute’s Clinical Proteomics Technologies Application for Cancer (CPTAC) Program. He received a number of awards including a Young Investigator’s Award in 2004 HUPO meeting. He has published more than 100 peer-reviewed articles in DNA repair, biochemistry, and proteomics related journals and book chapters, and served as an expert reviewer for many high-impact journals as well as NIH and the U.S. Department of Defense grant applications.